.svg){kind=logo}
Recent Posts
Breast cancer remains the most common cancer among women in the U.S.; the average risk of a woman developing breast cancer in her lifetime is 1 in 8. For some women with additional risk factors, including a family or personal...
What is inflammatory breast cancer, and how is it different from other types of breast cancer?
Inflammatory breast cancer (IBC) is a rare and particularly aggressive form of breast cancer, in which cancer cells clog the lymph...
Invasive (or infiltrating) lobular carcinoma (ILC) is a type of breast cancer that began in the milk-producing lobules, which empty into the ducts that carry milk to the nipple, and has spread into surrounding tissue. It is the...
What is LCIS?
Lobular carcinoma in situ (LCIS) describes the growth of abnormal cells in the breast lobules, the milk-producing glands at the ends of the milk ducts. “In situ” means that the abnormal cells are contained in their...
The American Cancer Society’s (ACS) recent release of yet another set of mammography screening guidelines is adding to the confusion over just when and how often women should undergo mammography. Despite this move by the ACS,...
Paul Keller was born in California to parents who were both college professors, one in physics and one in mathematics. The family, which includes his two brothers, moved to Northfield, Minnesota when Paul was 12. He remained in...
Ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, is the most common form of non-invasive breast cancer, accounting for about 20% of all new breast cancer cases. “Ductal” indicates that the cancer is found...
If you or your provider notices a lump or abnormality in your breast tissue, after other non-invasive diagnostic imaging like mammograms, CT scanning, or breast MRI, he or she may have recommended you undergo a biopsy. A biopsy...
